1887

n South African Medical Journal - Genetic profiling in breast cancer : editorials

USD

 

Abstract

Of women with early breast cancer who receive chemotherapy 70 - 80% do not benefit from the treatment, but 1 - 5% with an 'excellent' prognosis experience recurrence and should have been given the benefit of the extra therapy. More accurate markers are needed to reflect the disease prognosis and predict response to treatment.

Loading

Article metrics loading...

/content/m_samj/101/11/EJC67462
2011-11-01
2016-12-06
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error